These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12686539)

  • 1. Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels.
    Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D
    J Biol Chem; 2003 Jun; 278(26):23343-51. PubMed ID: 12686539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells.
    Hendriks BS; Orr G; Wells A; Wiley HS; Lauffenburger DA
    J Biol Chem; 2005 Feb; 280(7):6157-69. PubMed ID: 15572377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3.
    Shankaran H; Zhang Y; Tan Y; Resat H
    PLoS Comput Biol; 2013; 9(8):e1003201. PubMed ID: 23990774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking.
    Shankaran H; Zhang Y; Opresko L; Resat H
    Biochem Biophys Res Commun; 2008 Jun; 371(2):220-4. PubMed ID: 18424261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects.
    Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D
    Cancer Res; 2003 Mar; 63(5):1130-7. PubMed ID: 12615732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
    Muthuswamy SK; Gilman M; Brugge JS
    Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
    Earp HS; Dawson TL; Li X; Yu H
    Breast Cancer Res Treat; 1995 Jul; 35(1):115-32. PubMed ID: 7612898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms.
    Hendriks BS; Wiley HS; Lauffenburger D
    Biophys J; 2003 Oct; 85(4):2732-45. PubMed ID: 14507736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
    Monsey J; Shen W; Schlesinger P; Bose R
    J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
    Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
    Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.
    Patel D; Bassi R; Hooper A; Prewett M; Hicklin DJ; Kang X
    Int J Oncol; 2009 Jan; 34(1):25-32. PubMed ID: 19082474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-HER-An antibody mixture targeting EGFR, HER2 and HER3 abrogates preformed and ligand-induced EGFR homo- and heterodimers.
    Ellebaek S; Brix S; Grandal M; Lantto J; Horak ID; Kragh M; Poulsen TT
    Int J Cancer; 2016 Nov; 139(9):2095-105. PubMed ID: 27342948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation.
    Trenker R; Diwanji D; Bingham T; Verba KA; Jura N
    Elife; 2024 Mar; 12():. PubMed ID: 38498590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization drives EGFR endocytosis through two sets of compatible endocytic codes.
    Wang Q; Chen X; Wang Z
    J Cell Sci; 2015 Mar; 128(5):935-50. PubMed ID: 25588832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
    Gilbertson RJ; Perry RH; Kelly PJ; Pearson AD; Lunec J
    Cancer Res; 1997 Aug; 57(15):3272-80. PubMed ID: 9242460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.
    Wang Z; Zhang L; Yeung TK; Chen X
    Mol Biol Cell; 1999 May; 10(5):1621-36. PubMed ID: 10233167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response.
    Shankaran H; Wiley HS; Resat H
    Biophys J; 2006 Jun; 90(11):3993-4009. PubMed ID: 16533841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization.
    Hughes JB; Berger C; Rødland MS; Hasmann M; Stang E; Madshus IH
    Mol Cancer Ther; 2009 Jul; 8(7):1885-92. PubMed ID: 19584234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
    Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
    Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.